Product Information

ROPINIROLE HCL 2 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0664 per EA under NDC 62332003331. Its NADAC has been published 537 times since May 11, 2016.

FDA first approved this application on Mar 24, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROPINIROLE HCL 2 MG TABLET

ROPINIROLE
$0.0664per EA

Strength

2 mg/1

NDC

62332003331

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ROPINIROLE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090429

FDA Approved

3/24/2010

TE Code

AB

On Market Since

1/29/2016

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price Statistics

The NADAC for ROPINIROLE HCL 2 MG TABLET has been published 537 times since May 11, 2016, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0664 per EA
All-time high$0.1039 (Jan 11, 2017)
All-time low$0.0496 (Nov 20, 2024)
52-week high$0.0696
52-week low$0.0651
Median price$0.0671
Average price$0.0709
Largest weekly change-19.1% (Nov 20, 2024)
Weeks tracked537
Tracking sinceMay 11, 2016

Price History

1W

-1.1%

1M

-1.1%

3M

+0.2%

6M

-1.7%

1Y

-4.6%

3Y

-4.8%

5Y

+2.1%

All

-34.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ROPINIROLE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ROPINIROLE HCL 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 2 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0664 per EA (NDC 62332003331), effective Aug 19, 2026.

How has the price of ROPINIROLE HCL 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for ROPINIROLE HCL 2 MG TABLET has declined 34.6%. It has been tracked across 537 weekly CMS publications since May 11, 2016.

What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 2 MG TABLET?

Since May 11, 2016, the NADAC for ROPINIROLE HCL 2 MG TABLET has ranged from a low of $0.0496 (Nov 20, 2024) to a high of $0.1039 (Jan 11, 2017), with a median of $0.0671 per EA.

Are there cheaper alternatives to ROPINIROLE HCL 2 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ROPINIROLE HCL 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ROPINIROLE HCL 2 MG TABLET?

ROPINIROLE HCL 2 MG TABLET (NDC 62332003331) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.